Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 2CNS 2Sarcoma 1Other solid neoplasm 1Lymphoid 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 76Lymphoma 73Lymphoma, Non-Hodgkin 66Hodgkin Disease 53Leukemia 40Lymphoma, Large B-Cell, Diffuse 37Multiple Myeloma 35Myelodysplastic Syndromes 34Lymphoma, Mantle-Cell 33Leukemia, Myeloid, Acute 33Leukemia, Lymphocytic, Chronic, B-Cell 30Burkitt Lymphoma 30Lymphoma, Follicular 26Leukemia, Myelogenous, Chronic, BCR-ABL Positive 18Lymphoma, B-Cell, Marginal Zone 17Lymphoma, Large-Cell, Immunoblastic 15Recurrence 12Myeloproliferative Disorders 11Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10Neoplasms, Plasma Cell 9Hematologic Neoplasms 9Dendritic Cell Sarcoma, Interdigitating 9Lymphoma, T-Cell 8Leukemia, Myelomonocytic, Chronic 8Leukemia, Biphenotypic, Acute 8Primary Myelofibrosis 7Leukemia, Myelomonocytic, Juvenile 7Blast Crisis 7Waldenstrom Macroglobulinemia 6Neoplasms 6

Interventions

eltrombopag 3Etoposide 3Cytarabine 3romiplostim 2Platelet Transfusion 2Lenalidomide 2Filgrastim 2Cyclosporine 2Cyclophosphamide 2sodium thiosulfate 1siltuximab 1pegfilgrastim 1ofatumumab 1fludarabine phosphate 1etoposide phosphate 1avatrombopag 1alvocidib 1Vorinostat 1Vitamin E 1Vincristine 1Topotecan 1Thioguanine 1Surveys and Questionnaires 1Rituximab 1Ritonavir 1Radiotherapy 1Quality of Life 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Methotrexate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thrombocytopenia × Granulocyte Colony-Stimulating Factor × Lymphoid × Clear all
NCT00074165 2023-07-06

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

OHSU Knight Cancer Institute

Phase 2 Terminated
17 enrolled 7 charts
CNSClassical hematologyLymphoid

Lymphoma, Thrombocytopenia, Central Nervous System Neoplasms, Intraocular Lymphoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡